جستجوی استاد راهنمای دانشگاهی

Clay C.C. Wangمشاهده پروفایل

استاد

• Natural Products Drug Discovery
• Gene Regulation of Fungal Secondary Metabolism
• Sustainability
• +۳ مورد دیگر

Clay C.C. Wang serves as Professor and Chair of the Department of Pharmacology and Pharmaceutical Sciences at the University of Southern California's Mann School of Pharmacy, with a joint appointment in the Department of Chemistry at the Dornsife College of Letters, Arts and Sciences. His educational background includes: AB in Chemistry from Harvard University (1996) PhD in Chemistry from California Institute of Technology (2001) Postdoctoral Fellowship in Chemistry and Chemical Engineering at Stanford University Wang's research spans the chemistry-biology interface, focusing on natural product biosynthesis in microbial systems. His lab pioneers fungal host engineering using Aspergillus nidulans for sustainable production of high-value compounds, including plastic upcycling initiatives. Key expertise areas include Natural Products Drug Discovery, Fungal Secondary Metabolism Regulation, Space Biology, and Genomic Adaptation mechanisms. His 2019 publications reveal a cohesive research trajectory examining how space environments (particularly ISS conditions) alter fungal genomics, proteomics, and metabolite production. These studies demonstrate significant stress-induced adaptations in secondary metabolism across Aspergillus and Fusarium species, with implications for pharmaceutical discovery and extraterrestrial microbial ecology. Wang secured a landmark $600,000 NASA Space Biology Program grant (2014) enabling his team's ISS collaboration. His Wang Group holds patent 15338696 (2017) for engineered fungal strains with optimized natural product pathways, demonstrating translational impact from fundamental research. The Wang Lab operates at the nexus of pharmaceutical sciences and space microbiology, employing integrated -omics approaches to investigate fungal resilience in extreme environments while advancing sustainable drug discovery pipelines.

• Space Biology
• Microgravity Research
• Neurobiology
• +۵ مورد دیگر

Marcel Egli serves as Head of the Institute for Medical Technology (IMT) at the Lucerne University of Applied Sciences and Arts (HSLU) within the School of Engineering & Architecture. His institute combines the Center of Competence in Bioscience and Medical Engineering, the Space Biology Group, and the User Support and Operational Center BIOTESC that serves the European Space Agency (ESA). The IMT offers study programs and complementary post-graduate courses in medical technology. Dr. Egli's research focuses on cellular mechanisms of mechanosensation induced by mechanical unloading (weightlessness). His academic journey began with training as a precision mechanic, followed by a master's degree in zoology from the University of Berne and multidisciplinary graduate studies in medicine and biology. He conducted postdoctoral research at the University of Melbourne and Florida State University, where he became Associate Faculty studying secretory rhythms of hormones in mammals. His appointment to lead the Space Biology Group at ETH Zurich brought him back to Switzerland, where he received his Venia Legendi in space biology before moving his research group to Lucerne to establish the Institute of Medical Engineering. Egli's publication record demonstrates a clear trajectory from neurobiology and neuro-endocrinology toward space biology research. His recent work utilizes diverse research platforms including parabolic flight maneuvers, sounding rockets, and International Space Station laboratories to investigate cellular responses to microgravity. His research spans cellular mechanosensation, calcium signaling, tissue engineering, and the development of space-compatible biomedical instrumentation. Dr. Egli has led numerous significant projects including Space Bioreactor development, COSMOS Data Cockpit for Personalized Medicine, research on astronauts' low back pain, and the CaSiPaC project studying calcium signaling during parabolic flight in chondrocytes. His work has received support from space agencies including ESA and the Canadian Space Agency. The Institute for Medical Technology under Egli's leadership operates as a multidisciplinary hub connecting space research with terrestrial medical applications. His team develops technologies that function in both space environments and Earth-based clinical settings, with particular emphasis on understanding how mechanical unloading affects biological systems at the cellular level. This research has implications for both space medicine and understanding terrestrial conditions like osteoporosis and muscle atrophy.

• Medical Technology
• Ophthalmology
• Retinal Degeneration
• +۳ مورد دیگر

Christina Giger-Lange serves as a Lecturer at Lucerne University of Applied Sciences and Arts within the School of Engineering and Architecture's Department of Life Sciences and Medical Engineering. She heads the Oertli Research Lab for ophthalmic contract research and co-manages the microbiological analysis laboratory with the Health and Hygiene Research Group. Education: PhD in Retinal Cell Biology, University of Zurich (2007-2010) Master of Science in Biology and Neuroscience, ETH Zurich (2001-2006) Research Focus: Her work bridges ophthalmic surgical innovation and space biotechnology , with dual expertise in retinal degeneration mechanisms and microgravity effects on biological systems. Current projects include developing safer vitreous/cataract removal techniques and space bioreactors for tissue engineering, while maintaining foundational research in hypoxia signaling pathways. Publication Evolution: Early career (2008-2012) centered on retinal cell biology and JAK/STAT signaling in photoreceptor degeneration. Recent work (2018-2025) demonstrates strategic pivot toward space medicine, featuring parabolic flight experiments, microgravity simulators, and ophthalmic device optimization – reflecting growing institutional investment in medical technology for extreme environments. Research Leadership: Manages Innosuisse-funded projects including "Low back pain of astronauts," "Space Bioreactor," "Legionella control in buildings (LeCo)," and "Green Healthcare Buildings." Directs contract research for Oertli Instrumente AG in ophthalmology while mentoring junior researchers through the Institute for Medical Technology. Laboratory Infrastructure: Oversees two specialized facilities: the Oertli Research Lab for wet-lab ophthalmic instrumentation testing and a microbiological analysis lab supporting healthcare building safety research through the Health and Hygiene Research Group.

• Forensic Genetics
• Microbiome Research
• Aquaculture
• +۲ مورد دیگر

Louisa Pless is a Forensic geneticist in the Section of Forensic Genetics at the University of Copenhagen, based at Frederiksvej V's Vej 9-11, 2100 Copenhagen, Denmark. Her contact email is louisa.pless@sund.ku.dk and phone number is +4535321017. Her research bridges forensic genetics with cutting-edge microbiome science. Recent work focuses on Atlantic salmon gut microbiome dynamics across life stages, nutritional impacts on microbial health, and sustainable aquaculture applications. She also pioneers research into food fermentation technologies for space missions, addressing microbial challenges in extraterrestrial environments through interdisciplinary collaboration. Analysis of her 2024-2025 publications reveals a strategic shift toward high-resolution genomic characterization of microbiomes. Key trends include aquaculture optimization, space food safety, and environmental sustainability, leveraging advanced sequencing to solve real-world problems in food systems and marine biology. No scientific awards were documented in the available information. There is no public record of advised students or secured research grants in the provided materials. Dr. Pless operates within a robust international research network evident from extensive co-authorship across institutions. Her collaborative teams span microbiome analysis, aquaculture innovation, and space food technology development, frequently generating significant media attention as seen in the 62+ news outlets covering her Nature Microbiology publication.

• Exercise Physiology
• Cardiovascular Physiology
• Autonomic Neuroscience
• +۳ مورد دیگر

Lonnie Grove Petersen is an international researcher at the Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen. His work focuses on human physiological adaptations in extreme environments, particularly spaceflight and exercise stressors, with significant contributions to understanding cardiovascular, ocular, and thrombotic risks in microgravity. His research spans Exercise Physiology, Cardiovascular Regulation, Autonomic Neuroscience, and Space Medicine. Key investigations include neuro-ocular syndrome in astronauts, exercise-induced hormonal responses, and autonomic control mechanisms during gravitational stress. His methodology integrates human subject studies with translational approaches to address health challenges in space exploration and terrestrial applications. Analysis of his 2023-2025 publications reveals a dominant focus on space medicine, especially Spaceflight Associated Neuro-ocular Syndrome (SANS) and venous thrombosis risks. His work demonstrates strong interdisciplinary collaboration across cardiovascular physiology, exercise science, and aerospace medicine, with frequent use of human experimental models like lower body negative pressure and high-intensity exercise protocols. No scientific awards are explicitly documented in the provided information. While graduate student mentorship details are absent, Petersen maintains extensive international collaborations, particularly with European and North American space research institutions. His publication record indicates active grant-funded research, though specific funding sources are not disclosed in the source material. His research operates within Copenhagen's Department of Biomedical Sciences, leveraging the university's human physiology infrastructure. Collaborative networks include the European Space Agency-affiliated projects and multinational teams studying microgravity pathophysiology, with emphasis on developing countermeasures for long-duration space missions.